<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://feeds.resonaterecordings.com/feed.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <atom:link rel="self" type="application/atom+xml" href="https://feeds.resonaterecordings.com/inside-scope-aga-podcast" title="MP3 Audio" />
        <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/" />
                <title>Inside Scope</title>
                <generator>Resonate Recordings https://resonaterecordings.com</generator>
        <description>
            <![CDATA[Welcome to Inside Scope, the American Gastroenterological Association podcast that will help you advance your patient care, one half-hour segment at a time. Join us to hear from the experts, learn new skills, and stay abreast of changing best practices in gastroenterology patient care.]]>
        </description>
                    <copyright>© 2026 Inside Scope American Gastroenterological Association (AGA)</copyright>
                <language>en-us</language>
        <pubDate>Tue, 07 Apr 2026 10:03:49 +0000</pubDate>
        <lastBuildDate>Tue, 07 Apr 2026 10:03:49 +0000</lastBuildDate>
                    <link>http://agau.gastro.org/</link>
                <image>
            <url>https://storage.googleapis.com/com-resonaterecordings-public/cover-art/VvIq1RFNLrjGgNrtihxuyEyPdB2V7yICul6e92JP.jpg</url>
            <title>Inside Scope</title>
                            <link>http://agau.gastro.org/</link>
                    </image>

                <itunes:category text="Health &amp; Fitness"><itunes:category text="Medicine" /></itunes:category>
        
                
        
                
        
        <googleplay:author>American Gastroenterological Association (AGA)</googleplay:author>
        <googleplay:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/VvIq1RFNLrjGgNrtihxuyEyPdB2V7yICul6e92JP.jpg" />
        <googleplay:explicit>false</googleplay:explicit>

        <itunes:type>serial</itunes:type>
        <itunes:author>American Gastroenterological Association (AGA)</itunes:author>
        <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/VvIq1RFNLrjGgNrtihxuyEyPdB2V7yICul6e92JP.jpg" />
        <itunes:owner>
            <itunes:name>American Gastroenterological Association (AGA)</itunes:name>
            <itunes:email>agapodcast@gastro.org</itunes:email>
        </itunes:owner>
        <itunes:complete>No</itunes:complete>
        <itunes:explicit>false</itunes:explicit>

        
                <item>
            <title>Expert Exchange Nutrition in IBD: Perioperative Nutrition</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>14</itunes:season>
            
            <itunes:title>Expert Exchange Nutrition in IBD: Perioperative Nutrition</itunes:title>
            <itunes:subtitle>Welcome to episode four of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, introduce the principles of Enhanced Recovery After Su...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">f8f6fd29-d3c5-495c-a70e-e495d78ac8c4</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/f8f6fd29-d3c5-495c-a70e-e495d78ac8c4</link>
            <description>
                <![CDATA[Welcome to episode four of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, introduce the principles of Enhanced Recovery After Surgery (ERAS) and discuss how this evidence-based framework applies to the perioperative care of patients with inflammatory bowel disease (IBD). The conversation will explore the unique considerations for individuals with IBD undergoing surgery and highlight key strategies used to optimize surgical outcomes, including perioperative nutritional support, multidisciplinary care coordination, and patient-centered recovery planning. 

Listeners will gain practical insights into how ERAS principles can be integrated into clinical practice to support improved recovery, reduced complications, and better overall surgical outcomes for patients with IBD. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org  

This independent educational program was supported by an independent medical education grant from Pfizer.]]>
            </description>
            <pubDate>Tue, 17 Feb 2026 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/f8f6fd29-d3c5-495c-a70e-e495d78ac8c4.mp3"
                length="55959509"
                type="audio/mpeg" />
                                    <itunes:duration>1399</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Expert Exchange Nutrition in IBD: Managing Symptoms ( IBS/SIBO)</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>14</itunes:season>
            
            <itunes:title>Expert Exchange Nutrition in IBD: Managing Symptoms ( IBS/SIBO)</itunes:title>
            <itunes:subtitle>Welcome to episode five of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion focused on distinguishing the overla...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">0a86f8bb-6c04-43fc-920d-996f963e2caa</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/0a86f8bb-6c04-43fc-920d-996f963e2caa</link>
            <description>
                <![CDATA[Welcome to episode five of our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion focused on distinguishing the overlapping symptoms of irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) from inflammatory bowel disease (IBD). The conversation will examine how these conditions influence dietary choices and food-related quality of life (FRQoL), highlighting the clinical and psychosocial challenges patients often face. 

Listeners will gain practical insights into evidence-based approaches for both short-term and long-term management of IBS and SIBO, with an emphasis on individualized care strategies that minimize unnecessary dietary restriction while supporting symptom control and improved patient outcomes. 

To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org  

This independent educational program was supported by an independent medical education grant from Pfizer.]]>
            </description>
            <pubDate>Tue, 17 Feb 2026 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/0a86f8bb-6c04-43fc-920d-996f963e2caa.mp3"
                length="61251917"
                type="audio/mpeg" />
                                    <itunes:duration>1531</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Expert Exchange Nutrition in IBD: Myth Busters</title>
            <itunes:episode>6</itunes:episode>

                            <itunes:season>14</itunes:season>
            
            <itunes:title>Expert Exchange Nutrition in IBD: Myth Busters</itunes:title>
            <itunes:subtitle>Welcome to the final episode in our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion addressing common myths and mis...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d67078c5-b421-4a64-a5e5-5706c5530f86</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/d67078c5-b421-4a64-a5e5-5706c5530f86</link>
            <description>
                <![CDATA[Welcome to the final episode in our six-part series AGA Expert Exchange: Nutrition in IBD. Hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, lead a discussion addressing common myths and misinformation surrounding diet and nutrition in inflammatory bowel disease (IBD). The conversation will explore frequently debated topics, including the role of gluten and dairy in IBD-related inflammation, the evidence behind food intolerance testing, and perceptions around organic versus conventional foods and their impact on health. 

Listeners will gain evidence-based clarity to help dispel nutrition myths, counsel patients with confidence, and support informed, balanced dietary decision-making in the management of IBD. To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org  

This independent educational program was supported by an independent medical education grant from Pfizer.]]>
            </description>
            <pubDate>Tue, 17 Feb 2026 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d67078c5-b421-4a64-a5e5-5706c5530f86.mp3"
                length="76038268"
                type="audio/mpeg" />
                                    <itunes:duration>1901</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>MASH: Recognizing a &quot;Silent&quot; Disease</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>15</itunes:season>
            
            <itunes:title>MASH: Recognizing a &quot;Silent&quot; Disease</itunes:title>
            <itunes:subtitle>Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. 

These episodes have been developed in par...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">ea5307f5-e8b7-4e58-a121-1f750ad03b68</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/ea5307f5-e8b7-4e58-a121-1f750ad03b68</link>
            <description>
                <![CDATA[Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. 

These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. 

In episode one, “Recognizing a ‘Silent’ Disease,” Drs. Arun Sanyal and Mary Rinella will discuss MASH and the role that primary care physicians can play in its early detection and treatment. What are the challenges in diagnosing this often-silent disease? What do clinicians need to know to ensure that MASH doesn't fall off their radar? 

Listen as experts discuss challenges in MASLD/MASH diagnosis, including risk stratification of patients, and implications for diagnostic delays. Additionally, they’ll share strategies for incorporating noninvasive methods such as the FIB-4 score, NFS, APRI, and secondary assessments. Finally, the experts will emphasize the vital role PCPs play in MASH detection and management. 

This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting: https://suitehome.atpointofcare.com/library/2711.01/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.]]>
            </description>
            <pubDate>Fri, 30 Jan 2026 17:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/ea5307f5-e8b7-4e58-a121-1f750ad03b68.mp3"
                length="61376888"
                type="audio/mpeg" />
                                    <itunes:duration>1534</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>MASH: How to Treat and When to Refer</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>15</itunes:season>
            
            <itunes:title>MASH: How to Treat and When to Refer</itunes:title>
            <itunes:subtitle>Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. 

These episodes have been developed in par...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">05f48858-f2c1-44df-a6e1-6c4b3db44859</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/05f48858-f2c1-44df-a6e1-6c4b3db44859</link>
            <description>
                <![CDATA[Welcome to our two-episode series: MD3D: Metabolic dysfunction-associated steatohepatitis — The Role of Primary Care providers in the Growing Epidemic. 

These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured on both AGA’s Inside Scope podcast as well as PIK’s Morning Commute podcast. 

In episode two, “MASH: How to Treat and When to Refer,” Drs. Arun Sanyal and Mary Rinella take a look at the role that primary care physicians can play in the treatment of MASH, how can they treat and monitor these patients, and most importantly, when should a specialist be called in. 

Our experts will review current treatment guidelines and care pathways for MASH. They’ll discuss the role of PCPs in the multidisciplinary management of patients with MASH, including the referral of high-risk patients to specialists. Finally, they’ll share the management of underlying metabolic conditions, such as T2DM and obesity, in patients with MASH who are at low risk of fibrosis. 

This program is supported by an educational grant from Novo Nordisk. Information about the faculty and disclosures can be found by visiting : https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash. You can also use this link to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.]]>
            </description>
            <pubDate>Fri, 30 Jan 2026 17:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/05f48858-f2c1-44df-a6e1-6c4b3db44859.mp3"
                length=""
                type="audio/mpeg" />
                                    <itunes:duration></itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Expert Exchange Nutrition in IBD: Diet as Therapy</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>14</itunes:season>
            
            <itunes:title>Expert Exchange Nutrition in IBD: Diet as Therapy</itunes:title>
            <itunes:subtitle>Welcome to episode one of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas  and Kelly Issokson, RD, LDN, are joined by guest Dr. Dale Lee to discuss the ro...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">ca5b0e33-2921-41cd-942c-ec68ece2cd01</guid>
            <link>https://agau.gastro.org/Home</link>
            <description>
                <![CDATA[Welcome to episode one of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas  and Kelly Issokson, RD, LDN, are joined by guest Dr. Dale Lee to discuss the role of diet as a therapeutic approach for managing inflammatory bowel disease (IBD). The discussion will cover the distinction between symptoms and disease control, the use of enteral nutrition therapies, and the benefits of whole food-based diets. We will explore how exclusive enteral nutrition can be used to treat conditions like Crohn's disease and the importance of a close partnership with a dietitian. Our experts will also address the challenges and opportunities of using dietary therapy for IBD, including differences in nutritional therapy for adult versus pediatric patients and the future landscape of nutrition and IBD management. 

To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org  

This independent educational program was supported by an independent medical education grant from Pfizer]]>
            </description>
            <pubDate>Thu, 18 Dec 2025 11:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/ca5b0e33-2921-41cd-942c-ec68ece2cd01.mp3"
                length="49585588"
                type="audio/mpeg" />
                                    <itunes:duration>2066</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Expert Exchange Nutrition in IBD: Dietary Counseling in Clinical Practice/Working with an RD</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>14</itunes:season>
            
            <itunes:title>Expert Exchange Nutrition in IBD: Dietary Counseling in Clinical Practice/Working with an RD</itunes:title>
            <itunes:subtitle>Welcome to episode two of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Rotem Sigall Boneh, RD, to explore th...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">ec7562c5-18d3-478a-af00-a599d5132695</guid>
            <link>https://agau.gastro.org/Home</link>
            <description>
                <![CDATA[Welcome to episode two of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Rotem Sigall Boneh, RD, to explore the essential aspects of integrating nutritional expertise into inflammatory bowel disease (IBD) management. This episode will cover how to effectively collaborate with a GI dietitian, emphasizing strategies for personalizing dietary interventions to ensure the right diet is matched to the right patient at the right time. Additionally, the group discusses the practicalities of referring patients to a dietitian and clarifies the differences between a nutritionist and a registered dietitian, helping health care providers make informed decisions about patient care. 

 To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org

This independent educational program was supported by an independent medical education grant from Pfizer]]>
            </description>
            <pubDate>Thu, 18 Dec 2025 11:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/ec7562c5-18d3-478a-af00-a599d5132695.mp3"
                length="36188562"
                type="audio/mpeg" />
                                    <itunes:duration>1508</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Expert Exchange Nutrition in IBD: Malnutrition</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>14</itunes:season>
            
            <itunes:title>Expert Exchange Nutrition in IBD: Malnutrition</itunes:title>
            <itunes:subtitle>Welcome to episode three of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Victoria Christianson, RD, to explo...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">ac454d2e-2f86-41f3-9c8f-6662797e964f</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/ac454d2e-2f86-41f3-9c8f-6662797e964f</link>
            <description>
                <![CDATA[Welcome to episode three of our six-part series AGA Expert Exchange: Nutrition in IBD. Our hosts Dr. Eric Vasiliauskas and Kelly Issokson, RD, LDN, are joined by Victoria Christianson, RD, to explore the critical topic of malnutrition in inflammatory bowel disease (IBD). The discussion will begin with practical approaches to screening and assessment, highlighting key red flags that clinicians should recognize in both outpatient and inpatient settings. The conversation will then delve into the dual challenges of sarcopenia and obesity, examining how variations in fat mass can influence the clinical course of IBD and impact patient outcomes. 

Listeners will gain insights into the nuances of managing nutrition for ambulatory versus hospitalized patients, including considerations for those with NPO status. The episode will provide actionable strategies for identifying at-risk patients, tailoring interventions, and collaborating with multidisciplinary teams to optimize nutritional care across the continuum of IBD management. 

To view additional resources on nutrition in IBD and claim CME, please visit AGA University at agau.gastro.org  

This independent educational program was supported by an independent medical education grant from Pfizer]]>
            </description>
            <pubDate>Thu, 18 Dec 2025 11:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/ac454d2e-2f86-41f3-9c8f-6662797e964f.mp3"
                length="21740840"
                type="audio/mpeg" />
                                    <itunes:duration>1359</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>AGA Perspectives: When and how to stop surveillance colonoscopy</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>13</itunes:season>
            
            <itunes:title>AGA Perspectives: When and how to stop surveillance colonoscopy</itunes:title>
            <itunes:subtitle>There is some debate about when to recommend cessation of surveillance colonoscopy, especially in those who are 75-85 years old. In this episode of the AGA Perspectives series, Dr. Gyanprakash Ketw...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">f3dbb8a8-dab9-47b5-bcba-028d3fac0e7f</guid>
            <link>https://www.mdedge.com/gihepnews/article/263532/gi-oncology/surveillance-colonoscopy-when-and-how-stop</link>
            <description>
                <![CDATA[There is some debate about when to recommend cessation of surveillance colonoscopy, especially in those who are 75-85 years old. In this episode of the AGA Perspectives series, Dr. Gyanprakash Ketwaroo and Dr. Moamen Gabr are joined by Dr. Mariam Naveed and Dr. Petr Protiva to discuss this common but tricky topic.]]>
            </description>
            <pubDate>Wed, 03 Dec 2025 18:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/f3dbb8a8-dab9-47b5-bcba-028d3fac0e7f.mp3"
                length="33733390"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/YZl2wlHFkqf5J2BGL9V79d1T2SVyKfMldCcHhcY7.jpg" />
                        <itunes:duration></itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>AGA Perspectives: Surgical vs. endoscopic excision of large colon polyps</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>13</itunes:season>
            
            <itunes:title>AGA Perspectives: Surgical vs. endoscopic excision of large colon polyps</itunes:title>
            <itunes:subtitle>In this episode of the AGA Perspective series, Dr. Gyanprakash Ketwaroo hosts a discussion on the best practices for removing large or complex colon polyps. Joined by Drs. Jeffrey Mosko and Moamen ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">a687603a-fefa-4098-ad63-6d0f1dadb599</guid>
            <link>https://www.mdedge.com/gihepnews/article/272266/endoscopy/surgical-vs-endoscopic-excision-large-colon-polyps</link>
            <description>
                <![CDATA[In this episode of the AGA Perspective series, Dr. Gyanprakash Ketwaroo hosts a discussion on the best practices for removing large or complex colon polyps. Joined by Drs. Jeffrey Mosko and Moamen Gabr, the conversation explores the evolution of endoscopic techniques, the importance of careful polyp selection, and the challenges faced in advanced tissue resection. The experts share insights on complications associated with EMR and ESD procedures, emphasizing the need for meticulous technique to ensure patient safety. In the second half of the episode, Dr. Ira Leeds offers a counterpoint, urging caution when managing polyps in the cecum and rectum,  while highlighting the role of minimally invasive surgical approaches.]]>
            </description>
            <pubDate>Fri, 11 Jul 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/a687603a-fefa-4098-ad63-6d0f1dadb599.mp3"
                length="65504864"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/VNKc7AqT3kkLuF1rLje2qKJS1lrXayCBJ8a9oOBW.jpg" />
                        <itunes:duration>1638</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>HE: Inadequate practices in the inpatient setting</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>12</itunes:season>
            
            <itunes:title>HE: Inadequate practices in the inpatient setting</itunes:title>
            <itunes:subtitle>In episode three of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by co-host Dr...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">cc6f33a1-4c37-4104-9bd6-46e6c96cce8d</guid>
            <link>https://agau.gastro.org/cw/course-details?entryId=17823071&amp;itemId=764911&amp;subscribed=false</link>
            <description>
                <![CDATA[In episode three of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by co-host Dr. Lisa Byers, an assistant professor within the hospital medicine department at the University of Rochester School of Medicine. They discuss the inadequate practices for HE management in the inpatient setting.  

To claim CME for listening, please visit AGA University at agau.gastro.org 

This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. ]]>
            </description>
            <pubDate>Wed, 21 May 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/cc6f33a1-4c37-4104-9bd6-46e6c96cce8d.mp3"
                length="22737536"
                type="audio/mpeg" />
                                    <itunes:duration>1421</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>HE: Current and emerging treatment modalities</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>12</itunes:season>
            
            <itunes:title>HE: Current and emerging treatment modalities</itunes:title>
            <itunes:subtitle>Welcome to episode one of our six-part series on hepatic encephalopathy (HE), a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients.  

I...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d318a68c-19df-45d7-98cf-51ca0ce45f88</guid>
            <link>https://agau.gastro.org/cw/course-details?entryId=17823071&amp;itemId=764911&amp;subscribed=false</link>
            <description>
                <![CDATA[Welcome to episode one of our six-part series on hepatic encephalopathy (HE), a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients.  

In this episode, Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Robert Rahimi, a board-certified physician in transplant hepatology, gastroenterology and internal medicine practicing at Baylor University Medical Center, as well as an associate professor of medicine at Texas A&M. They will discuss current and emerging treatment modalities for HE.  

To claim CME for listening, please visit AGA University at agau.gastro.org 

This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. ]]>
            </description>
            <pubDate>Wed, 21 May 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d318a68c-19df-45d7-98cf-51ca0ce45f88.mp3"
                length="31431503"
                type="audio/mpeg" />
                                    <itunes:duration>1964</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>HE: Changing epidemiology of cirrhosis and hepatic encephalopathy</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>12</itunes:season>
            
            <itunes:title>HE: Changing epidemiology of cirrhosis and hepatic encephalopathy</itunes:title>
            <itunes:subtitle>In episode two of our six-part series on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical Center, is jo...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">70fbec00-247e-4d04-80a9-b12cdbf33220</guid>
            <link>https://agau.gastro.org/cw/course-details?entryId=17823071</link>
            <description>
                <![CDATA[In episode two of our six-part series on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical Center, is joined by Dr. Elliot Tapper, an associate professor in the division of gastroenterology and hepatology at  University of Michigan, the director of the Michigan cirrhosis program and the editor in chief of Hepatology Communications. They discuss the changing epidemiology of cirrhosis and hepatic encephalopathy.  

To claim CME for listening, please visit AGA University at agau.gastro.org 

This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC.  ]]>
            </description>
            <pubDate>Wed, 21 May 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/70fbec00-247e-4d04-80a9-b12cdbf33220.mp3"
                length="71942157"
                type="audio/mpeg" />
                                    <itunes:duration>1799</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>HE: Specific challenges in geriatric cirrhosis and HE</title>
            <itunes:episode>6</itunes:episode>

                            <itunes:season>12</itunes:season>
            
            <itunes:title>HE: Specific challenges in geriatric cirrhosis and HE</itunes:title>
            <itunes:subtitle>In our final episode on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical, is joined by co-host Dr. Robe...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d39016f5-908c-44a1-b1d7-01ab1f1f8874</guid>
            <link>https://agau.gastro.org/cw/course-details?entryId=17823071&amp;itemId=764911&amp;subscribed=false</link>
            <description>
                <![CDATA[In our final episode on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical, is joined by co-host Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine. They delve into the article "Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy," authored by Drs. Jasmohan S. Bajaj, Angela Gentilly, James Wade, and Michael Godschalk, and published in Clinical Gastroenterology and Hepatology. Together, they explore best practices for staying current with the evolving literature and research on these conditions and discuss strategies for integrating new insights into daily clinical practice.  

To claim CME for listening, please visit AGA University at agau.gastro.org.  

This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. ]]>
            </description>
            <pubDate>Wed, 21 May 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d39016f5-908c-44a1-b1d7-01ab1f1f8874.mp3"
                length="39061352"
                type="audio/mpeg" />
                                    <itunes:duration>2441</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>HE: Strategies to prevent readmission from inadequate transitions of care</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>12</itunes:season>
            
            <itunes:title>HE: Strategies to prevent readmission from inadequate transitions of care</itunes:title>
            <itunes:subtitle>In episode five of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Craig R...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">358cdc42-12b6-4184-8ea9-3753e07ca2c5</guid>
            <link>https://agau.gastro.org/cw/course-details?entryId=17823071&amp;itemId=764911&amp;subscribed=false</link>
            <description>
                <![CDATA[In episode five of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Craig Rosenstengle, a fellow at Baylor University Medical Center in the combined gastroenterology and transplant hepatology pathway. They will discuss hepatic encephalopathy and strategies to prevent readmissions from inadequate transitions of care.  

To claim CME for listening, please visit AGA University at agau.gastro.org 

This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. ]]>
            </description>
            <pubDate>Wed, 21 May 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/358cdc42-12b6-4184-8ea9-3753e07ca2c5.mp3"
                length="37027368"
                type="audio/mpeg" />
                                    <itunes:duration>1157</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>HE: Missed diagnosis of cirrhosis in the inpatient setting</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>12</itunes:season>
            
            <itunes:title>HE: Missed diagnosis of cirrhosis in the inpatient setting</itunes:title>
            <itunes:subtitle>In episode four of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Alpesh ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">eb3d2e62-d877-4ca8-b094-cdaec3ececd3</guid>
            <link>https://agau.gastro.org/cw/course-details?entryId=17823071&amp;itemId=764911&amp;subscribed=false</link>
            <description>
                <![CDATA[In episode four of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Alpesh Amin, a professor of medicine at the University of California, Irvine ( UCI), the endowed chair of the UCI School of Medicine Department of Medicine, and the executive director of UCI's Hospitalist Program. They discuss missed diagnosis in the inpatient setting.  

To claim CME for listening, please visit AGA University at agau.gastro.org. 

This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. ]]>
            </description>
            <pubDate>Wed, 21 May 2025 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/eb3d2e62-d877-4ca8-b094-cdaec3ececd3.mp3"
                length="38039936"
                type="audio/mpeg" />
                                    <itunes:duration>1189</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>EoE: Picking the Right Tool For the Job</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>11</itunes:season>
            
            <itunes:title>EoE: Picking the Right Tool For the Job</itunes:title>
            <itunes:subtitle>Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between Ameri...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">dfdcdb8e-0f1c-4f58-a788-e8a6bde0df0d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/dfdcdb8e-0f1c-4f58-a788-e8a6bde0df0d</link>
            <description>
                <![CDATA[Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel.   

Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index. 

 Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. 

Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.]]>
            </description>
            <pubDate>Tue, 18 Feb 2025 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/dfdcdb8e-0f1c-4f58-a788-e8a6bde0df0d.mp3"
                length="21160793"
                type="audio/mpeg" />
                                    <itunes:duration>1323</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>EoE: Why I-SEE Matters and Evidence To-Date</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>11</itunes:season>
            
            <itunes:title>EoE: Why I-SEE Matters and Evidence To-Date</itunes:title>
            <itunes:subtitle>Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between Ameri...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">f733d3d8-359e-49ae-b0ed-0f0b8e919c1f</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/f733d3d8-359e-49ae-b0ed-0f0b8e919c1f</link>
            <description>
                <![CDATA[Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel.   
 
Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Dr. Evan Dellon and Dr. Emily McGowan discuss the features measured by the I-SEE clinical index and its role in evaluating EoE severity, as well as evidence behind the ongoing validation of this tool and implications for future use.   

Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. 

Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.02/page/0  to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.]]>
            </description>
            <pubDate>Tue, 18 Feb 2025 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/f733d3d8-359e-49ae-b0ed-0f0b8e919c1f.mp3"
                length="20809679"
                type="audio/mpeg" />
                                    <itunes:duration>1301</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Clinical Practice Updates: Help your patients with nonalcoholic fatty liver disease (NAFLD) lose weight</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>10</itunes:season>
            
            <itunes:title>Clinical Practice Updates: Help your patients with nonalcoholic fatty liver disease (NAFLD) lose weight</itunes:title>
            <itunes:subtitle>Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. 

Originally released as a bonus episode in January 2023, this episode shares key insights from th...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">5240c4e7-6e0d-42dc-b8fc-2fc8b74a6747</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/5240c4e7-6e0d-42dc-b8fc-2fc8b74a6747</link>
            <description>
                <![CDATA[Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. 

Originally released as a bonus episode in January 2023, this episode shares key insights from the AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease (published in the February 2021 issue of Gastroenterology).  

This episode is hosted by Dr. Jana Al Hashash, member of the AGA Clinical Practice Update Committee. She is joined by:

-Dr. Heather Patton, NAFLD expert and past member of the AGA Clinical Practice Update Committee

-Dr. Joseph K. Lim, past chair of the AGA Clinical Practice Update Committee and co-author of this CPU

-Dr. Zobair M Younossi, co-author of this CPU

To access the full expert review, visit www.gastro.org/CPU.]]>
            </description>
            <pubDate>Tue, 19 Nov 2024 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/5240c4e7-6e0d-42dc-b8fc-2fc8b74a6747.mp3"
                length="75496988"
                type="audio/mpeg" />
                                    <itunes:duration>1887</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Clinical Practice Update: Diet and nutritional therapies for IBD</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>10</itunes:season>
            
            <itunes:title>Clinical Practice Update: Diet and nutritional therapies for IBD</itunes:title>
            <itunes:subtitle>Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

This episode shares key insights from the AGA Clinical Practice Update: Diet and Nutritional Th...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">fa287c98-8559-4535-a5d8-486199afbd46</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/fa287c98-8559-4535-a5d8-486199afbd46</link>
            <description>
                <![CDATA[Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

This episode shares key insights from the AGA Clinical Practice Update: Diet and Nutritional Therapies (published in the March 2024 issue of Gastroenterology).

This episode is hosted by Dr. Jana Al Hashash, chair of the AGA Clinical Practice Update Committee. She is joined by authors  

-Dr. David Binion, professor of medicine and co-director of the IBD Center, director of nutrition support service, at UPMC Presbyterian Hospital and University of Pittsburgh; co-author of CPU   

-Dr. James Lewis, professor of medicine and epidemiology at the Perelman School of Medicine at the University of Pennsylvania ; co-author of CPU

-Ms. Kelly Issokson, registered dietitian and clinical coordinator of digestive diseases at Cedars-Sinai in Los Angeles 

To access the full Clinical Practice Update, visit www.gastro.org/CPU.]]>
            </description>
            <pubDate>Tue, 19 Nov 2024 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/fa287c98-8559-4535-a5d8-486199afbd46.mp3"
                length="36021839"
                type="audio/mpeg" />
                                    <itunes:duration>2251</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Clinical Practice Update: Diagnosis and management of cyclic vomiting syndrome</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>10</itunes:season>
            
            <itunes:title>Clinical Practice Update: Diagnosis and management of cyclic vomiting syndrome</itunes:title>
            <itunes:subtitle>Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

This episode shares key insights from the AGA Clinical Practice Update: Diagnosis and Managemen...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">ef0e2574-d46b-4471-a705-f56f2dea2e2a</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/ef0e2574-d46b-4471-a705-f56f2dea2e2a</link>
            <description>
                <![CDATA[Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

This episode shares key insights from the AGA Clinical Practice Update: Diagnosis and Management of Cyclic Vomiting Syndrome (published in the September 2024 issue of Gastroenterology). We dive into why gastroenterologists and hepatologists should think about a diagnosis of cyclic vomiting syndrome when seeing patients who report recurrent nausea and vomiting symptoms and discuss strategies for therapy.   

This episode is hosted by Dr. Kyle Staller, CPU author and member of the AGA Clinical Practice Updates Committee. He is joined by fellow authors: 

-Dr. David Levinthal, assistant professor of medicine at the University of Pittsburgh and director of the UPMC Neurogastroenterology and Motility Center 

-Dr. Thangam Venkatesan, professor of internal medicine and head of the neurogastroenterology and motility section at The Ohio State University Wexner Medical Center 

To access the full Clinical Practice Update, visit www.gastro.org/CPU.]]>
            </description>
            <pubDate>Tue, 19 Nov 2024 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/ef0e2574-d46b-4471-a705-f56f2dea2e2a.mp3"
                length="23962616"
                type="audio/mpeg" />
                                    <itunes:duration>1498</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Clinical Practice Update: Alpha-gal syndrome for the GI clinician</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>10</itunes:season>
            
            <itunes:title>Clinical Practice Update: Alpha-gal syndrome for the GI clinician</itunes:title>
            <itunes:subtitle>Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

This special episode of Inside Scope shares key insights from the AGA Clinical Practice Update ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">efa9b7d9-1295-4cc2-8de0-32d2b04bfc21</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/efa9b7d9-1295-4cc2-8de0-32d2b04bfc21</link>
            <description>
                <![CDATA[Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

This special episode of Inside Scope shares key insights from the AGA Clinical Practice Update on Alpha-Gal Syndrome for the GI Clinician. 

Originally released as a bonus episode March 2024, this episode shares key insights from the AGA Clinical Practice Update (CPU) on Alpha-Gal Syndrome for the GI Clinician (published in the April 2023 issue of Clinical Gastroenterology and Hepatology). 

This episode is hosted by Dr. Jana Al Hashash, chair-elect of the AGA Clinical Practice Update Committee and one of the CPU authors. She is joined by her co-authors: 

-Dr. Sarah McGill, gastroenterologist and associate professor of medicine at the University of North Carolina

-Dr. Thomas Platts-Mills, professor of medicine and microbiology and chief at the University of Virginia, a pioneer in discovery of alpha-gal syndrome

-Dr. Hannah Dodson, nurse Practitioner affiliated with the University of North Carolina and a patient sharing her perspective on navigating life with alpha-gal syndrome 

To access the full Clinical Practice Update, visit https://www.gastro.org/CPU]]>
            </description>
            <pubDate>Tue, 19 Nov 2024 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/efa9b7d9-1295-4cc2-8de0-32d2b04bfc21.mp3"
                length="26106413"
                type="audio/mpeg" />
                                    <itunes:duration>1632</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Clinical Practice Update: Endoscopic approach to recurrent acute and chronic pancreatitis</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>10</itunes:season>
            
            <itunes:title>Clinical Practice Update: Endoscopic approach to recurrent acute and chronic pancreatitis</itunes:title>
            <itunes:subtitle>Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

Originally released as a bonus episode in June 2023, this episode shares recommendations from t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">c85a1f74-d268-421f-a270-09258ed35576</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/c85a1f74-d268-421f-a270-09258ed35576</link>
            <description>
                <![CDATA[Enhance your patient care skills with this season covering select AGA Clinical Practice Updates.  

Originally released as a bonus episode in June 2023, this episode shares recommendations from the AGA Clinical Practice Update (CPU) on the Endoscopic Approach to Recurrent Acute and Chronic Pancreatitis (published in the October 2022 issue of Gastroenterology). 

This episode is hosted by Dr. Jana Al Hashash, chair of the AGA Clinical Practice Update Committee and an author of this CPU. She is joined by: 

Dr. Greg Coté, professor of medicine at Oregon Health Science University.   

Dr. Daniel Strand, associate professor of interventional endoscopy at University of Virginia.  

Dr. Ryan Law, doctor of osteopathic medicine at the Mayo Clinic, Rochester.  

To access the full Clinical Practice Update, visit www.gastro.org/CPU.]]>
            </description>
            <pubDate>Tue, 19 Nov 2024 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/c85a1f74-d268-421f-a270-09258ed35576.mp3"
                length="29798528"
                type="audio/mpeg" />
                                    <itunes:duration>1862</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Hepatorenal syndrome–acute kidney injury: Current pharmacologic therapies</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>9</itunes:season>
            
            <itunes:title>Hepatorenal syndrome–acute kidney injury: Current pharmacologic therapies</itunes:title>
            <itunes:subtitle>Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode two, our host Muhamad Nadeem Yousaf, MD, speaks with Nikki Duong, MD, to disc...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d085bbaa-b669-4a8e-ad14-1cde8c2a6239</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/d085bbaa-b669-4a8e-ad14-1cde8c2a6239</link>
            <description>
                <![CDATA[Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode two, our host Muhamad Nadeem Yousaf, MD, speaks with Nikki Duong, MD, to discuss the nomenclature, pharmacological options, and care recommendations for HRS-AKI patients. 

Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. 

To read the related journal articles and claim CME for listening, visit agau.gastro.org.  

This series is supported by an independent educational grant from Mallinckrodt]]>
            </description>
            <pubDate>Tue, 02 Apr 2024 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d085bbaa-b669-4a8e-ad14-1cde8c2a6239.mp3"
                length="28830874"
                type="audio/mpeg" />
                                    <itunes:duration>721</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Hepatorenal syndrome–acute kidney injury: Diagnosis and non-pharmacological management</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>9</itunes:season>
            
            <itunes:title>Hepatorenal syndrome–acute kidney injury: Diagnosis and non-pharmacological management</itunes:title>
            <itunes:subtitle>Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode three, our host Muhamad Nadeem Yousaf, MD, speaks with Nikhilesh Mazumder, MD...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">3980caef-e7e6-45ad-89b4-86cfea827db8</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/3980caef-e7e6-45ad-89b4-86cfea827db8</link>
            <description>
                <![CDATA[Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode three, our host Muhamad Nadeem Yousaf, MD, speaks with Nikhilesh Mazumder, MD, MPH, Shilpa Junna, MD, and Pratima Sharma, MD, MBBS, MS, to discuss initial management of patients with HRS-AKI. They’ll explore topics such as the efficacy of non-selective beta-blockers, the recommended plasma expander for those with decompensated cirrhosis, the roles of renal replacement therapy (RRT), TIPS, and extracorporeal liver support system (ELSS), and the significance of liver transplant in the context of HRS-AKI. 

Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. 

To read the related journal articles and claim CME for listening, visit agau.gastro.org.  

This series is supported by an independent educational grant from Mallinckrodt]]>
            </description>
            <pubDate>Tue, 02 Apr 2024 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/3980caef-e7e6-45ad-89b4-86cfea827db8.mp3"
                length="29628032"
                type="audio/mpeg" />
                                    <itunes:duration>1852</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Hepatorenal syndrome–acute kidney injury: Liver transplantation</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>9</itunes:season>
            
            <itunes:title>Hepatorenal syndrome–acute kidney injury: Liver transplantation</itunes:title>
            <itunes:subtitle>Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In our final episode, our host Muhamad Nadeem Yousaf, MD, speaks with Vivian Ortiz, MD, ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d22b8a02-3799-4266-94c9-2f1e928fc8d6</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/d22b8a02-3799-4266-94c9-2f1e928fc8d6</link>
            <description>
                <![CDATA[Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In our final episode, our host Muhamad Nadeem Yousaf, MD, speaks with Vivian Ortiz, MD, and Neil Shah, MD, to delve into critical aspects of HRS-AKI. They cover the prognosis after initial management, the significance of reversing renal impairment for liver transplant candidates, the predictive role of MELD score in HRS-AKI, treatment's impact on liver transplant waiting lists, decision-making between liver transplant alone or simultaneous liver-kidney transplant, timing considerations for kidney transplant post-liver transplant, and factors affecting post-transplant prognosis.  

Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. 

To read the related journal articles and claim CME for listening, visit agau.gastro.org.  

This series is supported by an independent educational grant from Mallinckrodt]]>
            </description>
            <pubDate>Tue, 02 Apr 2024 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d22b8a02-3799-4266-94c9-2f1e928fc8d6.mp3"
                length="19339337"
                type="audio/mpeg" />
                                    <itunes:duration>1209</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Hepatorenal syndrome–acute kidney injury: Pathophysiology</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>9</itunes:season>
            
            <itunes:title>Hepatorenal syndrome–acute kidney injury: Pathophysiology</itunes:title>
            <itunes:subtitle>Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode one, our host Muhamad Nadeem Yousaf, MD, speaks with Danielle Adebayo, MD, an...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">746feeee-9049-4cae-ad2c-bf66804d2577</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/746feeee-9049-4cae-ad2c-bf66804d2577</link>
            <description>
                <![CDATA[Welcome to our four-episode series: Raising Awareness of Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI). In episode one, our host Muhamad Nadeem Yousaf, MD, speaks with Danielle Adebayo, MD, and Florence Wong, MD, MBBS, FRCPC, to analyze the pathophysiology of HRS-AKI. They cover peripheral vasodilatation hypothesis shortcomings in HRS-AKI, vasoconstrictor systems, bacterial translocation, inflammation, renal dysfunction, and contributory factors like cholemic nephropathy and adrenal insufficiency, while also suggesting the potential of metabolomic studies for future insights. 

Each episode of this series corresponds to a journal article from a September 2023 supplement of Clinical Gastroenterology and Hepatology (CGH), the official clinical practice journal of the American Gastroenterological Association, focusing on addressing knowledge gaps in HRS-AKI. 

To read the related journal articles and claim CME for listening, visit https://agau.gastro.org/cw/course-details?entryId=14556831&subscribed=true.  

This series is supported by an independent educational grant from Mallinckrodt]]>
            </description>
            <pubDate>Tue, 02 Apr 2024 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/746feeee-9049-4cae-ad2c-bf66804d2577.mp3"
                length="77576636"
                type="audio/mpeg" />
                                    <itunes:duration>1939</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Gastro Grand Rounds: Drug-induced liver injury</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>7</itunes:season>
            
            <itunes:title>Gastro Grand Rounds: Drug-induced liver injury</itunes:title>
            <itunes:subtitle>Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Drs. Marwan Ghabril and Naga Chalasani to discuss their Gastro Grand Rounds article, &quot;A 68-Year-Old Woman ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d9eee40d-6bb8-4338-9097-fb23599a136a</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/d9eee40d-6bb8-4338-9097-fb23599a136a</link>
            <description>
                <![CDATA[Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Drs. Marwan Ghabril and Naga Chalasani to discuss their Gastro Grand Rounds article, "A 68-Year-Old Woman With Unexplained Liver Enzyme Elevation and Active Chronic Hepatitis: Beware of Drug-Induced Autoimmune-Like Hepatitis." https://www.gastrojournal.org/article/S0016-5085(23)05078-3/fulltext

Dr. Ghabril is a professor of medicine at Indiana University School of Medicine. Dr. Chalasani is the David W. Crabb professor of gastroenterology and hepatology and an adjunct professor of anatomy, cell biology, and physiology at Indiana University School of Medicine.

[0:27] Introduction of the authors and outline of the case.
[3:30] Initial thoughts from the authors upon patient presentation.
[7:29] After considering additional patient history, what do the authors think about the patient?
[10:34] Does the family history of the patient cause the authors to refine the diagnosis?
[11:52] Further thoughts from the authors after physical examination of the patient.
[14:47] What tests are recommended?
[18:55] Additional thoughts from the authors after further testing.
[21:06] Should we be testing for hepatitis E?
[22:56] Should noninvasive testing be used?
[25:11] What is the authors' plan to determine next steps?
[27:06] How long should the wait be before a biopsy?
[29:08] The patient underwent liver biopsy. How were the results interpreted?
[34:31] How long does it take to determine that an appropriate course of action was made?
[35:37] How is the patient counselled?
[38:43] The LiverTox database.
[41:41] Final thoughts from the authors.

Thank you for listening. Find this and other articles on our website at https://www.gastrojournal.org. We welcome your feedback. Please email us at gastro@gastro.org.

This discussion was recorded on Dec. 20, 2023, and reflects medical knowledge at that time. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent those of the American Gastroenterological Association. The content of this podcast is provided for general information purposes only and does not offer medical or any other type of professional advice.]]>
            </description>
            <pubDate>Tue, 12 Mar 2024 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d9eee40d-6bb8-4338-9097-fb23599a136a.mp3"
                length="41040512"
                type="audio/mpeg" />
                                    <itunes:duration>2565</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Diversity in IBD Trials: How Artificial Intelligence May Help</title>
            <itunes:episode>6</itunes:episode>

                            <itunes:season>8</itunes:season>
            
            <itunes:title>Diversity in IBD Trials: How Artificial Intelligence May Help</itunes:title>
            <itunes:subtitle>Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. 

In this s...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">a803cc79-55eb-4da3-be16-c1742d3a9d41</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/a803cc79-55eb-4da3-be16-c1742d3a9d41</link>
            <description>
                <![CDATA[Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials. 

In this supersized episode, co-host Dr. Ayanna Lewis is joined by guest Dr. Ryan Stidham, an associate professor at the University of Michigan holding appointments in the departments of medicine and computational medicine. Dr. Stidham is a medical data scientist and has a research program that focuses on the development and testing of new technologies for disease assessment and decision making in gastroenterology and general medicine. Today’s discussion will explore how artificial intelligence may help address challenges with participant recruitment for clinical trials, while also discussing the role of AI in the field of gastroenterology more broadly. 

This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.]]>
            </description>
            <pubDate>Wed, 27 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/a803cc79-55eb-4da3-be16-c1742d3a9d41.mp3"
                length="123952160"
                type="audio/mpeg" />
                                    <itunes:duration>3099</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Diversity in IBD Trials: The community GI’s perspective</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>8</itunes:season>
            
            <itunes:title>Diversity in IBD Trials: The community GI’s perspective</itunes:title>
            <itunes:subtitle>Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">c10d0114-93f8-480f-b54b-0e97e5fce12a</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/c10d0114-93f8-480f-b54b-0e97e5fce12a</link>
            <description>
                <![CDATA[Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this episode, co-host Dr. Ayanna Lewis is joined by guest Dr. Erica Cohen, an adult gastroenterologist, IBD specialist and director of the IBD Research Program at Capital Digestive Care in Washington, D.C. Today’s discussion focuses on the community GI’s perspective on clinical trials. 

This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.]]>
            </description>
            <pubDate>Wed, 27 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/c10d0114-93f8-480f-b54b-0e97e5fce12a.mp3"
                length="20501888"
                type="audio/mpeg" />
                                    <itunes:duration>1281</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Diversity in IBD Trials: Bringing research to the community</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>8</itunes:season>
            
            <itunes:title>Diversity in IBD Trials: Bringing research to the community</itunes:title>
            <itunes:subtitle>Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">8ce81376-0499-4ebe-8572-ff884c2b50b4</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/8ce81376-0499-4ebe-8572-ff884c2b50b4</link>
            <description>
                <![CDATA[Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this episode, co-host Dr. Erin Forster is joined by guest Kenneth Getz, professor of public health and community medicine and director of the Center for the Study of Drug Development at Tufts University School of Medicine. Ken is also the founder and chairman of the board of directors at CISCRP, a nonprofit dedicated to providing education and information about clinical research. Today's discussion will explore how we can bring awareness of and education on clinical research to the community.  

This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.]]>
            </description>
            <pubDate>Wed, 27 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/8ce81376-0499-4ebe-8572-ff884c2b50b4.mp3"
                length="21991808"
                type="audio/mpeg" />
                                    <itunes:duration>1374</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Diversity in IBD Trials: The role of the CRO</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>8</itunes:season>
            
            <itunes:title>Diversity in IBD Trials: The role of the CRO</itunes:title>
            <itunes:subtitle>Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">2dbed321-521c-4bc0-b8ae-a743cd0c342b</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/2dbed321-521c-4bc0-b8ae-a743cd0c342b</link>
            <description>
                <![CDATA[Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this episode, co-host Dr. Erin Forster is joined by guest Dr. Gabriela Radulescu, vice president of medical research and development at Alimentiv, a contract research organization (CRO) specializing in gastroenterology trials. Dr. Radulescu has more than 20 years of experience working in the pharmaceutical industry across multiple functions, including medical affairs, drug safety and pharmacovigilance, clinical research, real world evidence, and patient support programs. At Alimentiv, Dr. Radulescu provides medical leadership for sponsored clinical trials, operational oversight for R&D projects, and medical input to the business development teams.  Today’s discussion will explore how CROs are working with investigators and sponsors to increase the diversity of patients enrolling in clinical trials.  

This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.]]>
            </description>
            <pubDate>Wed, 27 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/2dbed321-521c-4bc0-b8ae-a743cd0c342b.mp3"
                length="68922920"
                type="audio/mpeg" />
                                    <itunes:duration>1723</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Diversity in IBD Trials: Changing how we talk to patients</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>8</itunes:season>
            
            <itunes:title>Diversity in IBD Trials: Changing how we talk to patients</itunes:title>
            <itunes:subtitle>Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">778e89ca-142e-4992-9427-d479c2181785</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/778e89ca-142e-4992-9427-d479c2181785</link>
            <description>
                <![CDATA[Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this episode, hosts Drs. Erin Forster and Ayanna Lewis are joined by Melodie Narain-Blackwell, the founder and president of Color of Crohn’s & Chronic Illness (COCCI). COCCI is a nonprofit dedicated to health equity in BIPOC communities that are challenged with digestive diseases and chronic illnesses. Melodie was diagnosed with Crohn’s disease at the age of 36, thirty years after her symptoms began, and has become a passionate health advocate for people of color who battle chronic illness. Today’s discussion focuses on how we talk about clinical research with patients. 

This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.]]>
            </description>
            <pubDate>Wed, 27 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/778e89ca-142e-4992-9427-d479c2181785.mp3"
                length="77604824"
                type="audio/mpeg" />
                                    <itunes:duration>1940</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Diversity in IBD Trials: Start with our workforce</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>8</itunes:season>
            
            <itunes:title>Diversity in IBD Trials: Start with our workforce</itunes:title>
            <itunes:subtitle>Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">d595209d-76d2-4ea4-be35-fa956d2ddecc</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/d595209d-76d2-4ea4-be35-fa956d2ddecc</link>
            <description>
                <![CDATA[Welcome to our six-part series: Increasing Diversity in IBD Clinical Trials. This program will explore how to become a clinical trialist and increase diversity in IBD clinical trials.  

In this episode, hosts Drs. Erin Forster and Ayanna Lewis are joined by Drs. Freddy Caldera and Jana Al Hashash, who were part of the inaugural class of participants in AGA’s GI Clinical Trialists Bootcamp program. Today’s discussion focuses on how diversifying participation in clinical trials starts with diversifying our workforce.   

This series is supported by educational grants from AbbVie Inc.; Amgen; Bristol-Myers Squibb Company; Genentech, a member of the Roche Group; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Pharmaceuticals U.S.A., Inc., and a quality improvement grant from Pfizer Inc.]]>
            </description>
            <pubDate>Wed, 27 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/d595209d-76d2-4ea4-be35-fa956d2ddecc.mp3"
                length="85211717"
                type="audio/mpeg" />
                                    <itunes:duration>2130</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Gastro Grand Rounds: Perianal Crohn’s disease</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>7</itunes:season>
            
            <itunes:title>Gastro Grand Rounds: Perianal Crohn’s disease</itunes:title>
            <itunes:subtitle>Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Dr. David Ballard and Dr. Parakkal Deepak to discuss their Gastro Grand Rounds article, &quot;Long-Standing Sym...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">80109b0e-5316-4970-bd02-c40f4360cb19</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/80109b0e-5316-4970-bd02-c40f4360cb19</link>
            <description>
                <![CDATA[Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Dr. David Ballard and Dr. Parakkal Deepak to discuss their Gastro Grand Rounds article, "Long-Standing Symptomatic Fistulizing Perianal Crohn’s Disease: Progression Beyond Inflammation."

https://www.gastrojournal.org/article/S0016-5085(23)04997-1/fulltext

Dr. Ballard is an assistant professor of radiology and director of the 3D Printing Lab at the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis.

Dr. Deepak is an Associate Professor of Medicine in the Division of Gastroenterology at Washington University School of Medicine in St. Louis.

[0:27] Introduction of the authors and outline of the case.

[2:29] What initial steps does a gastroenterologist take to manage a patient who presents with possible perianal Crohn’s disease?

[6:47] How does an imaging specialist plan for imaging of the perianal disease, and what techniques are used in support of the endoscopist or gastroenterologist?

[11:33] The role of point-of-care ultrasound in perianal disease.

[15:38] When is a colorectal surgeon brought on board, and what does a colorectal surgeon do when examining the patient?

[19:57] How does the clinician manage abscess and fistula?

[25:13] Are there any radiological signs that indicate that a particular fistula may be particularly difficult to manage?

[29:38] What is a standard treatment for perianal fistula that evolves to cancer?

[31:27] Did the patient notice a change in the nature of the discharge?

[32:35] Final thoughts from the authors.

Thank you for listening. Find this and other articles on our website at https://www.gastrojournal.org. We welcome your feedback. Please email us at gastro@gastro.org.

This discussion was recorded on Nov. 1, 2023, and reflects medical knowledge at that time. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent those of the American Gastroenterological Association. The content of this podcast is provided for general information purposes only and does not offer medical or any other type of professional advice.]]>
            </description>
            <pubDate>Mon, 18 Dec 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/80109b0e-5316-4970-bd02-c40f4360cb19.mp3"
                length="35048192"
                type="audio/mpeg" />
                                    <itunes:duration>2191</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Gastro Grand Rounds: Managing diverticulitis</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>7</itunes:season>
            
            <itunes:title>Gastro Grand Rounds: Managing diverticulitis</itunes:title>
            <itunes:subtitle>Welcome to the first in a series of new podcast episodes from the pages of Gastroenterology, the flagship journal of the American Gastroenterological Association and the most prominent journal in t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">aed97792-7dc0-4cce-8b5c-1650f091581d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/aed97792-7dc0-4cce-8b5c-1650f091581d</link>
            <description>
                <![CDATA[Welcome to the first in a series of new podcast episodes from the pages of Gastroenterology, the flagship journal of the American Gastroenterological Association and the most prominent journal in the field of gastrointestinal disease. This podcast series covers articles in the journal’s “Gastro Grand Rounds” section, which features discussions among multidisciplinary teams of experts on the management of complex clinical cases.

Gastro Grand Rounds: Managing Diverticulitis
Dr. G.S. Raju, editor of the Gastro Grand Rounds section in Gastroenterology, is joined by Dr. Lisa Strate to discuss her article, “Recurrent Lower Abdominal Pain, Altered Bowel Habits, and Malaise: Conservative or Surgical Approach to a Common Disorder.”
https://www.gastrojournal.org/article/S0016-5085(23)00042-2/fulltext

Dr. Strate is a professor of medicine at the University of Washington School of Medicine and is the section head of gastroenterology at Harborview Medical Center.

Dr. Strate’s research has examined risk factors for the development of diverticular disease. Her work has informed the development of guidelines, dietary recommendations, and measurements for the prevention of diverticulitis. She has investigated the role of chronic inflammation and the gut microbiome in diverticulitis. She is a fellow of AGA.

[0:27] Introduction of the author.
[2:20] The utility of CT in evaluating diverticulitis.
[5:49] Managing a patient with uncomplicated diverticulitis.
[11:00] Take-home instructions for the patient.
[14:12] Preparing the patient colonoscopy, strategies used during the procedure, and documenting findings.
[19:11] Utility of a barium enema.
[20:22] The patient returns and has left lower quadrant pain. What are the next steps?
[24:30] Laying out the pros and cons of continued medical management compared with surgery for a patient who has recurrent episodes of uncomplicated diverticulitis.
[28:00] Does the author’s institution have a support group for patients?
[28:55] What is the longest period of antibiotics the author has given to a patient who does not want surgery?
[30:34] Take-home messages for fellows and residents.

Thank you for listening. Find this and other articles on our website at https://www.gastrojournal.org. We welcome your feedback. Please email us at gastro@gastro.org.

This discussion was recorded on Sept. 5, 2023, and reflects medical knowledge at that time. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent those of the American Gastroenterological Association. The content of this podcast is provided for general information purposes only and does not offer medical or any other type of professional advice.]]>
            </description>
            <pubDate>Mon, 13 Nov 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/aed97792-7dc0-4cce-8b5c-1650f091581d.mp3"
                length="32486513"
                type="audio/mpeg" />
                                    <itunes:duration>2030</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>C. diff: FMT and new microbiome therapies</title>
            <itunes:episode>6</itunes:episode>

                            <itunes:season>6</itunes:season>
            
            <itunes:title>C. diff: FMT and new microbiome therapies</itunes:title>
            <itunes:subtitle>Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">2b0e3fbc-49ea-4833-aa9c-d0a99b3773d9</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/2b0e3fbc-49ea-4833-aa9c-d0a99b3773d9</link>
            <description>
                <![CDATA[Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.    

In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Jessica Allegretti to discuss FMT and new microbiome therapies. 

You can now claim CME for listening – visit agau.gastro.org.  

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.]]>
            </description>
            <pubDate>Tue, 19 Sep 2023 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/2b0e3fbc-49ea-4833-aa9c-d0a99b3773d9.mp3"
                length="56453353"
                type="audio/mpeg" />
                                    <itunes:duration>1411</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>C. diff: Impact of rCDI on patients and their lives</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>6</itunes:season>
            
            <itunes:title>C. diff: Impact of rCDI on patients and their lives</itunes:title>
            <itunes:subtitle>Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">f1539b35-700d-437e-8d2a-a25a7d97a2fd</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/f1539b35-700d-437e-8d2a-a25a7d97a2fd</link>
            <description>
                <![CDATA[Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. 

In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Dr. Kevin Garey and a patient to discuss the impact of recurrent CDI on patients and their lives. 

This episode does not offer Continuing Medical Education (CME) credits.  

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.]]>
            </description>
            <pubDate>Tue, 29 Aug 2023 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/f1539b35-700d-437e-8d2a-a25a7d97a2fd.mp3"
                length="26418746"
                type="audio/mpeg" />
                                    <itunes:duration>1651</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>C. diff: Case management and transitions of care</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>6</itunes:season>
            
            <itunes:title>C. diff: Case management and transitions of care</itunes:title>
            <itunes:subtitle>Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">1c0abfb9-62fb-4a98-ab6e-51301ecbe974</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/1c0abfb9-62fb-4a98-ab6e-51301ecbe974</link>
            <description>
                <![CDATA[Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care. 

In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guests Rebecca Perez and Cheri Lattimer to discuss case management and transitions of care in C. difficile infection. 

You can now claim CME for listening – visit agau.gastro.org.  

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.]]>
            </description>
            <pubDate>Tue, 29 Aug 2023 09:45:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/1c0abfb9-62fb-4a98-ab6e-51301ecbe974.mp3"
                length="28692230"
                type="audio/mpeg" />
                                    <itunes:duration>1793</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>C. diff: Reconciling guideline differences for testing and treatment</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>6</itunes:season>
            
            <itunes:title>C. diff: Reconciling guideline differences for testing and treatment</itunes:title>
            <itunes:subtitle>Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">095f57c7-245d-4d05-b17f-bbcdb4415ae1</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/095f57c7-245d-4d05-b17f-bbcdb4415ae1</link>
            <description>
                <![CDATA[Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.    

In this episode, Drs. Paul Feuerstadt and Sahil Khanna are joined by guest Dr. Colleen Kelly to discuss how to reconcile guideline differences for testing and treatment of C. difficile. 

You can now claim CME for listening – visit agau.gastro.org.  

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.]]>
            </description>
            <pubDate>Tue, 29 Aug 2023 09:30:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/095f57c7-245d-4d05-b17f-bbcdb4415ae1.mp3"
                length="66923660"
                type="audio/mpeg" />
                                    <itunes:duration>1673</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>C. diff: Microbiota changes</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>6</itunes:season>
            
            <itunes:title>C. diff: Microbiota changes</itunes:title>
            <itunes:subtitle>Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging t...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">679ff36a-1246-46f4-8295-5fb8863d76f5</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/679ff36a-1246-46f4-8295-5fb8863d76f5</link>
            <description>
                <![CDATA[Welcome to our new six-episode series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.    

In this episode, Drs. Paul Feuerstadt and Sahil Khanna describe the shifts in the microbiota with C. difficile infection. This episode was originally released as a bonus episode in November 2022. 

You can now claim CME for listening – visit agau.gastro.org.  

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.]]>
            </description>
            <pubDate>Tue, 29 Aug 2023 09:15:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/679ff36a-1246-46f4-8295-5fb8863d76f5.mp3"
                length="21708314"
                type="audio/mpeg" />
                                    <itunes:duration>1357</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>C. diff: Risk factors</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>6</itunes:season>
            
            <itunes:title>C. diff: Risk factors</itunes:title>
            <itunes:subtitle>Welcome to our new six-part series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging trea...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">54a2a040-efad-42a5-8a28-66e6174a9f17</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/54a2a040-efad-42a5-8a28-66e6174a9f17</link>
            <description>
                <![CDATA[Welcome to our new six-part series: C. difficile: Preparing the Field for Change. This program will explore how to take a patient-centered approach to treatment and diagnosis, explore emerging treatment options, and discuss best practices for transitions of care.  

In this episode, Drs. Paul Feuerstadt and Sahil Khanna cover risk factors for initial and recurrent C. difficile infection. This episode was originally released as a bonus episode in November 2022. 

You can now claim CME for listening – visit agau.gastro.org.  

This series is supported by educational grants from Aimmune Therapeutics, Inc., Seres Therapeutics, and Ferring Pharmaceuticals, Inc.]]>
            </description>
            <pubDate>Tue, 29 Aug 2023 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/54a2a040-efad-42a5-8a28-66e6174a9f17.mp3"
                length="24509303"
                type="audio/mpeg" />
                                    <itunes:duration>1532</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Innovation in Duodenoscope Design: Making sense of endoscope reprocessing guidelines</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>5</itunes:season>
            
            <itunes:title>Innovation in Duodenoscope Design: Making sense of endoscope reprocessing guidelines</itunes:title>
            <itunes:subtitle>Welcome to the final episode of our series Innovation in Duodenoscope Design. Guest host Nina Nandy, MD, is joined by Michael L. Kochman, MD, AGAF, to discuss the recently published multisociety gu...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">ac5b9632-14e7-4147-9f09-0618090f5f3a</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/ac5b9632-14e7-4147-9f09-0618090f5f3a</link>
            <description>
                <![CDATA[Welcome to the final episode of our series Innovation in Duodenoscope Design. Guest host Nina Nandy, MD, is joined by Michael L. Kochman, MD, AGAF, to discuss the recently published multisociety guideline on reprocessing flexible GI endoscopes and if the recommendations put forth are sufficient to address the current challenges posed by duodenoscope-related infections.

This series is supported by an unrestricted educational grant from Boston Scientific.

To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.]]>
            </description>
            <pubDate>Tue, 25 Apr 2023 15:45:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/ac5b9632-14e7-4147-9f09-0618090f5f3a.mp3"
                length="18203264"
                type="audio/mpeg" />
                                    <itunes:duration>1138</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Innovation in Duodenoscope Design: Are disposable scopes the answer?</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>5</itunes:season>
            
            <itunes:title>Innovation in Duodenoscope Design: Are disposable scopes the answer?</itunes:title>
            <itunes:subtitle>Episode 2 of our new series Innovation in Duodenoscope Design is all about disposable scopes! Join host Adarsh Thaker, MD, and his guests Gregory A. Cote, MD, and Andrew Ross, MD, as they cover:
...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">f3b40a1d-db82-4a24-8475-edd1dfe0f292</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/f3b40a1d-db82-4a24-8475-edd1dfe0f292</link>
            <description>
                <![CDATA[Episode 2 of our new series Innovation in Duodenoscope Design is all about disposable scopes! Join host Adarsh Thaker, MD, and his guests Gregory A. Cote, MD, and Andrew Ross, MD, as they cover:

•	How to determine whether a scope is clean or not and how to know it is ready for the next patient.
•	Cost and reimbursement factors into declaring that the risk of exogenous is "low".
•	If single use duodenoscopes make sense not only in infection prevention but also in the cost to the environment.

This series is supported by an unrestricted educational grant from Boston Scientific.

To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.]]>
            </description>
            <pubDate>Tue, 25 Apr 2023 15:45:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/f3b40a1d-db82-4a24-8475-edd1dfe0f292.mp3"
                length="31447766"
                type="audio/mpeg" />
                                    <itunes:duration>1965</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Innovation in Duodenoscope Design: FDA’s approach to post-market surveillance</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>5</itunes:season>
            
            <itunes:title>Innovation in Duodenoscope Design: FDA’s approach to post-market surveillance</itunes:title>
            <itunes:subtitle>Welcome to our new series Innovation in Duodenoscope Design! Episode one is hosted by Adarsh Thaker, MD. He is joined by Shani Haugen, PhD, who will help us understand how the FDA is addressing duo...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">52f4e3b3-f47b-4ac2-add3-626bdc0dce04</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/52f4e3b3-f47b-4ac2-add3-626bdc0dce04</link>
            <description>
                <![CDATA[Welcome to our new series Innovation in Duodenoscope Design! Episode one is hosted by Adarsh Thaker, MD. He is joined by Shani Haugen, PhD, who will help us understand how the FDA is addressing duodenoscope-related infection issues. They’ll answer key questions like what do FDA’s Safety Communications mean for GIs, what have we learned from 522 studies, and what do we still have to learn?

This series is supported by an unrestricted educational grant from Boston Scientific.

To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.]]>
            </description>
            <pubDate>Tue, 25 Apr 2023 15:45:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/52f4e3b3-f47b-4ac2-add3-626bdc0dce04.mp3"
                length="21904721"
                type="audio/mpeg" />
                                    <itunes:duration>1369</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Innovation in Duodenoscope Design: Opportunities with single-use scopes beyond infection control</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>5</itunes:season>
            
            <itunes:title>Innovation in Duodenoscope Design: Opportunities with single-use scopes beyond infection control</itunes:title>
            <itunes:subtitle>Uzma Siddiqui, MD, is here to host episode 3 of our series Innovation in Duodenoscope Design! She’s joined by Amrita Sethi, MD, to discuss opportunities with single-use scopes beyond infection cont...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">189b814b-95ff-4b43-9bca-3d7316e3706d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/189b814b-95ff-4b43-9bca-3d7316e3706d</link>
            <description>
                <![CDATA[Uzma Siddiqui, MD, is here to host episode 3 of our series Innovation in Duodenoscope Design! She’s joined by Amrita Sethi, MD, to discuss opportunities with single-use scopes beyond infection control, with a focus on ergonomic design. They’ll talk through how disposable scopes impact workflow both on and off the unit. Continue listening for a discussion on advantages and disadvantages of the widespread use of disposable scopes now and in the future. 

This series is supported by an unrestricted educational grant from Boston Scientific.

To find additional resources and learn more about Innovation in Duodenoscope Design, visit scopeinnovation.gastro.org.]]>
            </description>
            <pubDate>Tue, 25 Apr 2023 15:45:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/189b814b-95ff-4b43-9bca-3d7316e3706d.mp3"
                length="44348204"
                type="audio/mpeg" />
                                    <itunes:duration>1109</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Biosimilars: The logistics of switching between biosimilars or between biosimilars and reference product</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>4</itunes:season>
            
            <itunes:title>Biosimilars: The logistics of switching between biosimilars or between biosimilars and reference product</itunes:title>
            <itunes:subtitle>Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.

In episode 3 of 4, ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">b9b2e0a6-a38b-4a8c-af7d-52921164422d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/b9b2e0a6-a38b-4a8c-af7d-52921164422d</link>
            <description>
                <![CDATA[Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.

In episode 3 of 4, we're joined by guests Shuba Bhat, PharmD, and Jennifer Seminerio-Diehl, MD, to discuss:
•	What are the practical logistics when you work on a switch with a patient?
•	How do you address a situation where a patient says they are experiencing an increase in symptoms after a switch?
•	Are there any situations where you would consider appealing an insurance decision and not switching? 
•	What tests do you use to determine whether a patient is experiencing active disease before or after a switch? 

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Fri, 16 Dec 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/b9b2e0a6-a38b-4a8c-af7d-52921164422d.mp3"
                length="37886888"
                type="audio/mpeg" />
                                    <itunes:duration>947</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Biosimilars: Communicating with a patient who does not want to switch</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>4</itunes:season>
            
            <itunes:title>Biosimilars: Communicating with a patient who does not want to switch</itunes:title>
            <itunes:subtitle>Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.

In episode 4 of 4, ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">23fd603f-b02a-48a1-a5bb-c456ca1eb7ba</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/23fd603f-b02a-48a1-a5bb-c456ca1eb7ba</link>
            <description>
                <![CDATA[Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Dr. Christina Ha. Each episode features a challenging patient case and short discussion.

In episode 4 of 4, we're joined by guests Shuba Bhat, PharmD, and Miguel Regueiro, MD, to discuss:

•	Their approach to shared decision-making with a patient that’s concerned about a switch. And how often does this occur? 
•	Do you suggest that the patient speak with multiple team members?  
•	As a clinical pharmacist how do you counsel these patients?
•	What is the general approach to switching used at Cleveland Clinic and what do you find has been most helpful? 

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Fri, 16 Dec 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/23fd603f-b02a-48a1-a5bb-c456ca1eb7ba.mp3"
                length="36881516"
                type="audio/mpeg" />
                                    <itunes:duration>922</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Biosimilars: Managing switch scenarios with biologics and biosimilars</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>4</itunes:season>
            
            <itunes:title>Biosimilars: Managing switch scenarios with biologics and biosimilars</itunes:title>
            <itunes:subtitle>Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">da0a4e0e-c357-4ae4-b5e2-81e77c0b1b2d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/da0a4e0e-c357-4ae4-b5e2-81e77c0b1b2d</link>
            <description>
                <![CDATA[Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In episode 2 of 4, we’ll discuss:

•	How do you prepare your team and the patient for a switch to a biosimilar?
•	Are there any situations where switching is not appropriate?
•	What do you think about multiple switches?
•	How do you minimize the potential for a nocebo effect?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Fri, 16 Dec 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/da0a4e0e-c357-4ae4-b5e2-81e77c0b1b2d.mp3"
                length="14281127"
                type="audio/mpeg" />
                                    <itunes:duration>893</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Biosimilars: Starting a patient on biologic therapy</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>4</itunes:season>
            
            <itunes:title>Biosimilars: Starting a patient on biologic therapy</itunes:title>
            <itunes:subtitle>Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">66c2a0f8-1d26-45b5-92b1-a7b46e969fa4</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/66c2a0f8-1d26-45b5-92b1-a7b46e969fa4</link>
            <description>
                <![CDATA[Welcome to our four-part series Biosimilars: Addressing the Knowledge Gaps, hosted by Drs. Christina Ha and Frank Scott. Each episode features a challenging patient case and short discussion.

In episode 1 of 4, we’ll discuss:

•	How do you explain biosimilars to a patient with moderate-to-severe Crohn’s disease when you start them on a biologic?
•	What are some of the common questions that patients ask and how do you address them?
•	Do you set goals of therapy with your patients and what are they?

This series is supported by independent medical education grants from Amgen and Pfizer.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Mon, 12 Dec 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/66c2a0f8-1d26-45b5-92b1-a7b46e969fa4.mp3"
                length="14136704"
                type="audio/mpeg" />
                                    <itunes:duration>884</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Colorectal cancer: What you need to know now — the USPSTF guidelines</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>3</itunes:season>
            
            <itunes:title>Colorectal cancer: What you need to know now — the USPSTF guidelines</itunes:title>
            <itunes:subtitle>This is episode 1 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode covers what clinicians need to know regarding the updated colorectal cancer screenings guidance from ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">21744376-0efa-4308-bb0b-49266a507fa8</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/21744376-0efa-4308-bb0b-49266a507fa8</link>
            <description>
                <![CDATA[This is episode 1 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode covers what clinicians need to know regarding the updated colorectal cancer screenings guidance from the U.S. Preventive Services Task Force.

In this episode:
•	David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University 
•	Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center 

This season is supported by an independent medical education grant from Exact Sciences.]]>
            </description>
            <pubDate>Mon, 03 Oct 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/21744376-0efa-4308-bb0b-49266a507fa8.mp3"
                length="19310564"
                type="audio/mpeg" />
                                    <itunes:duration>1207</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Colorectal cancer: Working with your 45-49 patients on colorectal cancer screening</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>3</itunes:season>
            
            <itunes:title>Colorectal cancer: Working with your 45-49 patients on colorectal cancer screening</itunes:title>
            <itunes:subtitle>This is episode 2 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about strategies for promoting initiation of colorectal cancer screening at age 45 and addressing ...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">89892d27-75f5-432a-ae8a-36209eb5ebd4</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/89892d27-75f5-432a-ae8a-36209eb5ebd4</link>
            <description>
                <![CDATA[This is episode 2 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about strategies for promoting initiation of colorectal cancer screening at age 45 and addressing early-onset colorectal cancer.

In this episode:
•	David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University 
•	Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center
•	Samir Gupta, MD, associate professor of clinical medicine at the University of California San Diego and the San Diego Veterans Affairs Healthcare System

This season is supported by an independent medical education grant from Exact Sciences.]]>
            </description>
            <pubDate>Mon, 03 Oct 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/89892d27-75f5-432a-ae8a-36209eb5ebd4.mp3"
                length="19414397"
                type="audio/mpeg" />
                                    <itunes:duration>1213</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Colorectal cancer: Managing high-risk populations in primary care</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>3</itunes:season>
            
            <itunes:title>Colorectal cancer: Managing high-risk populations in primary care</itunes:title>
            <itunes:subtitle>This is episode 3 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about the importance of primary care providers in identifying and managing patients at high risk f...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">706b49f2-b39c-4b0f-93b7-25989fa27d01</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/706b49f2-b39c-4b0f-93b7-25989fa27d01</link>
            <description>
                <![CDATA[This is episode 3 of our 5-part series Colorectal Cancer: Screening to Save Lives. This episode is about the importance of primary care providers in identifying and managing patients at high risk for colorectal cancer.

In this episode:
•	David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University 
•	Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center
•	Swati Patel, MD, associate professor and director of the Gastrointestinal Cancer Risk and Prevention Center at the University of Colorado School of Medicine Anschutz Medical Campus. 

This season is supported by an independent medical education grant from Exact Sciences.]]>
            </description>
            <pubDate>Mon, 03 Oct 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/706b49f2-b39c-4b0f-93b7-25989fa27d01.mp3"
                length="24193280"
                type="audio/mpeg" />
                                    <itunes:duration>1512</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Colorectal cancer: Eliminating screening barriers for high-risk populations</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>3</itunes:season>
            
            <itunes:title>Colorectal cancer: Eliminating screening barriers for high-risk populations</itunes:title>
            <itunes:subtitle>This is episode 4 of our 5-part series Colorectal Cancer: Screening to Save Lives. We talk about important considerations when caring for individuals at high risk for poor outcomes in colorectal ca...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">f13dd4df-6df0-450f-8a73-cccab5e5f1c4</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/f13dd4df-6df0-450f-8a73-cccab5e5f1c4</link>
            <description>
                <![CDATA[This is episode 4 of our 5-part series Colorectal Cancer: Screening to Save Lives. We talk about important considerations when caring for individuals at high risk for poor outcomes in colorectal cancer due to social determinants of health.

In this episode:

•	David Lieberman, MD, professor of medicine in the division of Gastroenterology and Hepatology at the Oregon Health & Science University 
•	Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center

This season is supported by an independent medical education grant from Exact Sciences.]]>
            </description>
            <pubDate>Mon, 03 Oct 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/f13dd4df-6df0-450f-8a73-cccab5e5f1c4.mp3"
                length="22589435"
                type="audio/mpeg" />
                                    <itunes:duration>1412</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Colorectal cancer: Getting paid: Updated information about coverage, cost-sharing, reimbursement, coding</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>3</itunes:season>
            
            <itunes:title>Colorectal cancer: Getting paid: Updated information about coverage, cost-sharing, reimbursement, coding</itunes:title>
            <itunes:subtitle>In our final episode of our 5-part series Colorectal Cancer: Screening to Save Lives, we share updated information about coverage, cost-sharing, reimbursement and coding for colorectal cancer scree...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">c736e407-68ae-4e2d-8439-d3eed6b7375d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/c736e407-68ae-4e2d-8439-d3eed6b7375d</link>
            <description>
                <![CDATA[In our final episode of our 5-part series Colorectal Cancer: Screening to Save Lives, we share updated information about coverage, cost-sharing, reimbursement and coding for colorectal cancer screening.

In this episode:

•	David Lieberman, MD, professor of medicine in the division of gastroenterology and hepatology at the Oregon Health & Science University 
•	Chyke Doubeni, MD, chief health equity officer for the Ohio State University Wexner Medical Center and associate director for diversity, equity and inclusion for The Ohio State University Comprehensive Cancer Center
•	Shivan Mehta, MD, assistant professor of medicine and health policy at Perelman School of Medicine and associate chief innovation officer at Penn Medicine Center for Innovation

This season is supported by an independent medical education grant from Exact Sciences.]]>
            </description>
            <pubDate>Mon, 03 Oct 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/c736e407-68ae-4e2d-8439-d3eed6b7375d.mp3"
                length="21001499"
                type="audio/mpeg" />
                                    <itunes:duration>1313</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Obesity in GI Care: Coverage and Reimbursement</title>
            <itunes:episode>6</itunes:episode>

                            <itunes:season>2</itunes:season>
            
            <itunes:title>Obesity in GI Care: Coverage and Reimbursement</itunes:title>
            <itunes:subtitle>This is episode 6 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approac...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">184cd759-1456-4d78-96ef-a7a0efec548a</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/184cd759-1456-4d78-96ef-a7a0efec548a</link>
            <description>
                <![CDATA[This is episode 6 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). 

In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely discuss:
•	The role of the gastroenterologists and hepatologists, gastroenterology and hepatology advanced practice providers (APP), and others in a care team for obesity management.
•	How to find information on coding and reimbursement for obesity management.
•	How treating obesity is beneficial for patients and practices.
•	Pearls from episodes 1-5 of the series.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Tue, 14 Jun 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/184cd759-1456-4d78-96ef-a7a0efec548a.mp3"
                length="26906219"
                type="audio/mpeg" />
                                    <itunes:duration>1682</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Obesity in GI Care: Evaluating outcomes, adapting treatment plans and the future</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>2</itunes:season>
            
            <itunes:title>Obesity in GI Care: Evaluating outcomes, adapting treatment plans and the future</itunes:title>
            <itunes:subtitle>This is episode 5 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approac...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">42fee8cf-0985-4268-a61b-3567f9e12de8</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/42fee8cf-0985-4268-a61b-3567f9e12de8</link>
            <description>
                <![CDATA[This is episode 5 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). 

In this episode, our host Dr. Andres Acosta is joined by Dr. John Magaña Morton to discuss:
•	Evaluating patient outcomes and measuring weight loss success in terms of reduced disease burden.
•	How to adapt treatment plans when interventions are unsuccessful.
•	The future of obesity care in gastroenterology.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Tue, 07 Jun 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/42fee8cf-0985-4268-a61b-3567f9e12de8.mp3"
                length="38328266"
                type="audio/mpeg" />
                                    <itunes:duration>2396</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Obesity in GI Care: Updates on devices</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>2</itunes:season>
            
            <itunes:title>Obesity in GI Care: Updates on devices</itunes:title>
            <itunes:subtitle>This is episode 4 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approac...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">be3b231f-a6ab-4d0d-b77e-30a255b0fc6c</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/be3b231f-a6ab-4d0d-b77e-30a255b0fc6c</link>
            <description>
                <![CDATA[This is episode 4 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). 

In this episode, our host Dr. Andres Acosta is joined by Dr. Barham Abu Dayyeh to discuss:
•	Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastroesophageal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer.
•	Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss.
•	Updates on devices for obesity management that are available now and a look into what may be available in the future.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Tue, 31 May 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/be3b231f-a6ab-4d0d-b77e-30a255b0fc6c.mp3"
                length="39235658"
                type="audio/mpeg" />
                                    <itunes:duration>2452</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Obesity in GI Care: Updates on medications</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>2</itunes:season>
            
            <itunes:title>Obesity in GI Care: Updates on medications</itunes:title>
            <itunes:subtitle>This is episode 3 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approac...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">7847d7d5-7d2c-4965-8ca7-a1344fa5f126</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/7847d7d5-7d2c-4965-8ca7-a1344fa5f126</link>
            <description>
                <![CDATA[This is episode 3 of 6 from our program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you’ll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). 

In this episode, our host Dr. Andres Acosta is joined by Dr. Janese Laster to discuss: 
•	Gastroenterologists and the GI care team should embrace obesity care as weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastroesophageal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer.
•	Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss.
•	Updates on medications for obesity management that are available now and a look into what may be available in the future.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Wed, 25 May 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/7847d7d5-7d2c-4965-8ca7-a1344fa5f126.mp3"
                length="29505797"
                type="audio/mpeg" />
                                    <itunes:duration>1844</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Obesity in GI Care: Diet options</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>2</itunes:season>
            
            <itunes:title>Obesity in GI Care: Diet options</itunes:title>
            <itunes:subtitle>This is episode 2 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you&#039;ll learn a comprehensive app...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">978ed61c-e5e4-49d5-8f77-cc21c0e0aa0d</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/978ed61c-e5e4-49d5-8f77-cc21c0e0aa0d</link>
            <description>
                <![CDATA[This is episode 2 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program). 

 In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Colleen Tewksbury to discuss:  
•	A deep dive into dietary approaches for obesity management including debating low carb versus low fat diets. 
•	Misconceptions that society has about dietary approaches to weight loss. 
•	The importance of an individualized approach versus a cure-all for everyone.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Tue, 10 May 2022 09:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/978ed61c-e5e4-49d5-8f77-cc21c0e0aa0d.mp3"
                length="35015618"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/ZkuHpkRC415dCu9JJCtqgIDf0gmDbLrUPqjubiYf.jpg" />
                        <itunes:duration>2188</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Obesity in GI Care: How I embraced it and why you should too</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>2</itunes:season>
            
            <itunes:title>Obesity in GI Care: How I embraced it and why you should too</itunes:title>
            <itunes:subtitle>This is episode 1 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you&#039;ll learn a comprehensive app...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">58fa72dd-9410-4285-86ec-b854fab257cc</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/58fa72dd-9410-4285-86ec-b854fab257cc</link>
            <description>
                <![CDATA[This is episode 1 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).

In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Naresh Gunaratnam to discuss: 
•	Weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastrointestinal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer. 
•	Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss.

To collect CME credit for listening, visit agau.gastro.org.]]>
            </description>
            <pubDate>Thu, 31 Mar 2022 19:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/58fa72dd-9410-4285-86ec-b854fab257cc.mp3"
                length="29658419"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/PabuTDfIWbrto657VxsUYf3pOaM9558GXn1e8J2m.jpg" />
                        <itunes:duration>1854</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>NASH: The burden</title>
            <itunes:episode>1</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>NASH: The burden</itunes:title>
            <itunes:subtitle>This is episode 1 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care talk about the real-world, practical implications of scree...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">81a0db23-8cf1-4e7f-8a69-621351371e81</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/81a0db23-8cf1-4e7f-8a69-621351371e81</link>
            <description>
                <![CDATA[This is episode 1 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care talk about the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. We start with a discussion on the prevalence of NAFLD and NASH and their clinical and economic burdens with guest Zobair Younossi, MD, president, medicine service line, Inova Health System.

To collect CME credit for listening, visit nash.gastro.org.]]>
            </description>
            <pubDate>Mon, 10 Jan 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/81a0db23-8cf1-4e7f-8a69-621351371e81.mp3"
                length="38313632"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/ITHepv1Iq50lX4I1m4yN5H3w7C1HD0RBZFxGOoGv.jpg" />
                        <itunes:duration>1916</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>NASH: Metabolic syndrome</title>
            <itunes:episode>2</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>NASH: Metabolic syndrome</itunes:title>
            <itunes:subtitle>Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities. 

This is episode 2 of our...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">75fbb2d1-4db5-428d-b534-1a1ea4773522</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/75fbb2d1-4db5-428d-b534-1a1ea4773522</link>
            <description>
                <![CDATA[Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities. 

This is episode 2 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.]]>
            </description>
            <pubDate>Mon, 10 Jan 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/75fbb2d1-4db5-428d-b534-1a1ea4773522.mp3"
                length="57588992"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/2LgqbgoFFXf7UWQUtfCGv0gfaUdvo44m8Ns3gEYJ.jpg" />
                        <itunes:duration>2879</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>NASH: Screening in the primary care setting</title>
            <itunes:episode>3</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>NASH: Screening in the primary care setting</itunes:title>
            <itunes:subtitle>Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting.

This is episode 3 of our 6-part podcast, N...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">e21da0d9-9f87-4974-87c4-fda4ec54bde3</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/e21da0d9-9f87-4974-87c4-fda4ec54bde3</link>
            <description>
                <![CDATA[Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting.

This is episode 3 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.]]>
            </description>
            <pubDate>Mon, 10 Jan 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/e21da0d9-9f87-4974-87c4-fda4ec54bde3.mp3"
                length="33991712"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/6u60xnrzBWooMSptjUtd9xdxsRaGvgIDzrhc4o9l.jpg" />
                        <itunes:duration>1700</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>NASH: Diagnosing NAFLD and NASH</title>
            <itunes:episode>4</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>NASH: Diagnosing NAFLD and NASH</itunes:title>
            <itunes:subtitle>Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH.
...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">9bc4efda-02bb-41e2-9056-4f797bac0013</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/9bc4efda-02bb-41e2-9056-4f797bac0013</link>
            <description>
                <![CDATA[Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH.

This is episode 4 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.]]>
            </description>
            <pubDate>Mon, 10 Jan 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/9bc4efda-02bb-41e2-9056-4f797bac0013.mp3"
                length="47266592"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/HaRol1zTJCevaYGMHFLrUGW9lYiJjypD6xGTSFwG.jpg" />
                        <itunes:duration>2363</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>NASH: Management strategies</title>
            <itunes:episode>5</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>NASH: Management strategies</itunes:title>
            <itunes:subtitle>Robert H. Eckel, MD, University of Colorado, discusses limitations in current data about managing NAFLD and NASH and emerging therapies.

This is episode 5 of our 6-part podcast, NASH: Take Actio...</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">7b1f708f-2cd4-4c96-b4df-f8ac20bb702b</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/7b1f708f-2cd4-4c96-b4df-f8ac20bb702b</link>
            <description>
                <![CDATA[Robert H. Eckel, MD, University of Colorado, discusses limitations in current data about managing NAFLD and NASH and emerging therapies.

This is episode 5 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.]]>
            </description>
            <pubDate>Mon, 10 Jan 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/7b1f708f-2cd4-4c96-b4df-f8ac20bb702b.mp3"
                length="59018432"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/wqgNHxR4RChptRxJ1JWG6RB8agT7WtueRuKmEMhX.jpg" />
                        <itunes:duration>2951</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>NASH: Working together</title>
            <itunes:episode>6</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>NASH: Working together</itunes:title>
            <itunes:subtitle>We close out this series chatting with Hashem El-Serag, MD, Baylor College of Medicine, about collaboration between primary care providers and specialists in managing patients with NAFLD and NASH....</itunes:subtitle>
            <itunes:episodeType>full</itunes:episodeType>
            <guid isPermaLink="false">8e74085f-3e99-457b-b3b8-48c19f440258</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/8e74085f-3e99-457b-b3b8-48c19f440258</link>
            <description>
                <![CDATA[We close out this series chatting with Hashem El-Serag, MD, Baylor College of Medicine, about collaboration between primary care providers and specialists in managing patients with NAFLD and NASH.

This is the final episode in our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. 

To collect CME credit for listening, visit nash.gastro.org.]]>
            </description>
            <pubDate>Mon, 10 Jan 2022 10:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/8e74085f-3e99-457b-b3b8-48c19f440258.mp3"
                length="39606752"
                type="audio/mpeg" />
                                    <itunes:image href="https://storage.googleapis.com/com-resonaterecordings-public/cover-art/iIrv8D1NxT9sAVAy6bQEKFBw4XR5oOkNlTaI4GK2.jpg" />
                        <itunes:duration>1980</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
                <item>
            <title>Trailer: NASH: Take Action!</title>
            <itunes:episode>0</itunes:episode>

                            <itunes:season>1</itunes:season>
            
            <itunes:title>Trailer: NASH: Take Action!</itunes:title>
            <itunes:subtitle>The NASH: Take Action! six-episode podcast series features interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome providing practical information for health care professionals...</itunes:subtitle>
            <itunes:episodeType>trailer</itunes:episodeType>
            <guid isPermaLink="false">826b13c8-d9d2-4be7-8a0b-d5610cedb6aa</guid>
            <link>https://app.resonaterecordings.com/hosting/inside-scope-aga-podcast/826b13c8-d9d2-4be7-8a0b-d5610cedb6aa</link>
            <description>
                <![CDATA[The NASH: Take Action! six-episode podcast series features interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome providing practical information for health care professionals on screening, diagnosing and managing these conditions. Collect up to 6 AMA PRA Category 1 credits for this activity by visiting nash.gastro.org.]]>
            </description>
            <pubDate>Fri, 07 Jan 2022 14:00:00 +0000</pubDate>
                        <enclosure
                url="https://media.resonaterecordings.com/inside-scope-aga-podcast/826b13c8-d9d2-4be7-8a0b-d5610cedb6aa.mp3"
                length="1918592"
                type="audio/mpeg" />
                                    <itunes:duration>96</itunes:duration>

            <itunes:explicit>false</itunes:explicit>
            <googleplay:explicit>false</googleplay:explicit>
                    </item>
        
    </channel>
</rss>
